Saturday, July 11, 2026

Drug profile · INN

gbp510

gbp510 (SKYCOVION) is an FDA-listed pharmaceutical active ingredient.

EMA: application withdrawn Antiinfectives for systemic use (J07) J07BX03
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — gbp510
Class
Antiinfectives for systemic use (J07)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

gbp510 (SKYCOVION) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN gbp510
Brand SKYCOVION
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BX03

Approval history

Authority Status Date
EMA application withdrawn

Related & competitor drugs

  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Frequently asked questions

What is gbp510?

gbp510 (SKYCOVION) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for gbp510?

SKYCOVION is a marketed brand name for gbp510. Check FDA Drugs@FDA for the current US label holder and prescribing information.